Global Research-Grade Genetic Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Research-Grade Genetic Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Research-grade genetic testing refers to basic research and drug development by scientists in genetics, mainly for researchers and research institutions.
Research-Grade Genetic Testing report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Research-Grade Genetic Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Complex Disease and Rare Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Research-Grade Genetic Testing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Research-Grade Genetic Testing key companies include Thermo Fisher Scientific, Oxford Nanopore Technologies, Illumina, Ambry Genetics, Qiagen, PerkinElmer, BGI Group, Novogene and DaAn Gene, etc. Thermo Fisher Scientific, Oxford Nanopore Technologies, Illumina are top 3 players and held % share in total in 2022.
Research-Grade Genetic Testing can be divided into Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), Genome-Wide Association Studies (GWAS) and Others, etc. Whole Exome Sequencing (WES) is the mainstream product in the market, accounting for % share globally in 2022.
Research-Grade Genetic Testing is widely used in various fields, such as Complex Disease, Rare Disease, Genetic Diversity and Others, etc. Complex Disease provides greatest supports to the Research-Grade Genetic Testing industry development. In 2022, global % share of Research-Grade Genetic Testing went into Complex Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Research-Grade Genetic Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Thermo Fisher Scientific
Oxford Nanopore Technologies
Illumina
Ambry Genetics
Qiagen
PerkinElmer
BGI Group
Novogene
DaAn Gene
Segment by Type
Whole Exome Sequencing (WES)
Whole Genome Sequencing (WGS)
Genome-Wide Association Studies (GWAS)
Others
Complex Disease
Rare Disease
Genetic Diversity
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Research-Grade Genetic Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Research-Grade Genetic Testing introduction, etc. Research-Grade Genetic Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Research-Grade Genetic Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Research-Grade Genetic Testing report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Research-Grade Genetic Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Complex Disease and Rare Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Research-Grade Genetic Testing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Research-Grade Genetic Testing key companies include Thermo Fisher Scientific, Oxford Nanopore Technologies, Illumina, Ambry Genetics, Qiagen, PerkinElmer, BGI Group, Novogene and DaAn Gene, etc. Thermo Fisher Scientific, Oxford Nanopore Technologies, Illumina are top 3 players and held % share in total in 2022.
Research-Grade Genetic Testing can be divided into Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), Genome-Wide Association Studies (GWAS) and Others, etc. Whole Exome Sequencing (WES) is the mainstream product in the market, accounting for % share globally in 2022.
Research-Grade Genetic Testing is widely used in various fields, such as Complex Disease, Rare Disease, Genetic Diversity and Others, etc. Complex Disease provides greatest supports to the Research-Grade Genetic Testing industry development. In 2022, global % share of Research-Grade Genetic Testing went into Complex Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Research-Grade Genetic Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher Scientific
Oxford Nanopore Technologies
Illumina
Ambry Genetics
Qiagen
PerkinElmer
BGI Group
Novogene
DaAn Gene
Segment by Type
Whole Exome Sequencing (WES)
Whole Genome Sequencing (WGS)
Genome-Wide Association Studies (GWAS)
Others
Segment by Application
Complex Disease
Rare Disease
Genetic Diversity
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Research-Grade Genetic Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Research-Grade Genetic Testing introduction, etc. Research-Grade Genetic Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Research-Grade Genetic Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices